Trends in HIV postexposure prophylaxis prescription and compliance after sexual exposure in Amsterdam, 2000-2004

Sexually Transmitted Diseases

Volumn 34, Issue 5, 2007, Pages 288-293

  Sonder, Gerard J B ^a   Van Den Hoek, Anneke ^a   Regez, Rosa M ^b   Brinkman, Kees ^a   Prins, Jan M ^c   Mulder, Jan Willem ^d   Veenstra, Jan ^b   Claessen, Frans A ^e   Coutinho, Roel A ^a,c  

^a MUNICIPAL HEALTH SERVICE   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d SLOTERVAART HOSPITAL   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INDINAVIR; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; NEVIRAPINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHEMOPROPHYLAXIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIARRHEA; DRUG ERUPTION; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EXPOSURE; FATIGUE; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; MYALGIA; NAUSEA; NETHERLANDS; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRESCRIPTION; RETROSPECTIVE STUDY; SCHOOL CHILD; SEROCONVERSION; SEXUAL CRIME; SEXUAL INTERCOURSE; SIDE EFFECT; SINGLE DRUG DOSE; TREND STUDY; VICTIM;

ADOLESCENT; ADULT; AGED; ANTI-HIV AGENTS; CHEMOPREVENTION; CHILD; CRIME VICTIMS; DELIVERY OF HEALTH CARE; DISEASE TRANSMISSION, HORIZONTAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HIV INFECTIONS; HUMANS; MEDICAL RECORDS; MIDDLE AGED; NETHERLANDS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; SEXUAL BEHAVIOR;

EID: 34248212861     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000237838.43716.ee     Document Type: Article

References (24)

1. Katz MH, Gerberding JL. Postexposure treatment of people exposed to the human immunodeficiency virus through sexual contact or injection-drug use. N Engl J Med 1997; 336:1097-1100.
2. Laporte A, Jourdan N, Bouvet E, et al. Post-exposure prophylaxis after non-occupational HIV exposure: Impact of recommendations on physicians' experiences and attitudes. AIDS 2002; 16:397-405.
3. Giele CM, Maw R, Carne CA, et al. Post-exposure prophylaxis for non-occupational exposure to HIV: Current clinical practice and opinions in the UK. Sex Transm Infect 2002; 78:130-132.
4. Richens J, Edwards SG, Sadiq ST. Can the promotion of post-exposure prophylaxis following sexual exposure to HIV (PEPSE) cause harm? Sex Transm Infect 2005; 81:190-191.
5. Terrence Higgins Trust 2004. Available at: www.pep.chapsonline.org.uk. Accessed June 13, 2006.
6. Fisher M. Can the promotion of post-exposure prophylaxis following sexual exposure to HIV (PEPSE) cause harm? Response. Sex Transm Infect 2005; 81:191-192.
7. George C, Alary M, Otis J, et al. Omega Study Group, Omega Cohort, Montreal, Quebec, Canada. Nonnegligible increasing temporal trends in unprotected anal intercourse among men who have sexual relations with other men in Montreal. AIDS 2006; 42:207-212.
8. Hart GJ, Williamson LM. Increase in HIV sexual risk behaviour in homosexual men in Scotland, 1996-2002: Prevention failure? Sex Transm Infect 2005; 81:367-372.
9. Elford J, Bolding G, Davis M, et al. Trends in sexual behaviour among London homosexual men 1998-2003: Implications for HIV prevention and sexual health promotion. Sex Transm Infect 2004; 80:451-454.
10. van der Bij AK, Stolte IG, Coutinho RA, et al. Increase of sexually transmitted infections, but not HIV, among young homosexual men in Amsterdam: Are STIs still reliable markers for HIV transmission? Sex Transm Infect 2005; 81:34-37.
11. Waldo CR, Stall RD, Coates TJ. Is offering post-exposure prevention for sexual exposures to HIV related to sexual risk behavior in gay men? AIDS 2000; 14:1035-1039.
12. Hospers HJ, Dörfler TT, Zuilhof W. Monitoronderzoek Amsterdam 2004. [in Dutch]. Schorerstichting, 2004. Available at:www.monitoronderzoekonline. nl/downloads/monitoronderzoek-amsterdam2004.pdf. Accessed June 13, 2006.
13. van der Snoek EM, de Wit JB, Mulder PG, et al. Incidence of sexually transmitted diseases and HIV infection related to perceived HIV/AIDS threat since highly active antiretroviral therapy availability in men who have sex with men. Sex Transm Dis 2005; 32:170-175.
14. Martin JN, Roland ME, Neilands TB, et al. Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior. AIDS 2004; 18:787-792.
15. Kahn JO, Martin JM, Roland ME, et al. Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: The San Francisco PEP study. J Infect Dis 2001; 183:707-714.
16. Schechter M, do Lago RF, Mendelsohn AB, et al. Praca Onze Study Team. Behavioral impact, acceptability, and HIV incidence among homosexual men with access to postexposure chemoprophylaxis for HIV. J Acquir Immun Defic Syndr 2004; 35:519-525.
17. van de Laar MJW, de Boer IM, Koedijk FDH, Op de Coul ELM. HIV and Sexually Transmitted Infections in The Netherlands in 2004. An Update, November 2005. RIVM report 441100022/2005. Available at: www. rivm.nl/bibliotheek/ rapporten/441100022.pdf. Accessed June 13, 2006.
18. Sonder GJB, Regez RM, Brinkman K, et al. Prophylaxis and follow-up after possible exposure to HIV, hepatitis B virus, and hepatitis C virus outside hospital: Evaluation of policy 2000-3. BMJ 2005; 330:825-829.
19. Netherlands Coordination Communicable Disease Control [Landelijke Coördinatiestructuur infectieziektenbestrijding, LCI]. Guideline regarding accidental exposure to blood and body fluids [in Dutch]. In: Steenbergen JE, Timen A, eds. LCI Guidelines Communicable Disease Control. The Hague, 1999.
20. Almeda J, Casabona J, Simon B, et al. Proposed recommendations for the management of HIV post-exposure prophylaxis after sexual, injecting drug or other exposures in Europe. Eurosurveillance 2004; 9:35-40.
21. Smith DK, et al. Antiretroviral postexposure prophylaxis after sexual, injecting-drug use, or other nonoccupational exposure to HIV in the United States. MMWR Morb Mortal Wkly Rep 2005; 54:1-20.
22. Linden JA, Oldeg P, Mehta SD, et al. HIV Postexposure prophylaxis in sexual assault: Current practice and patient adherence to treatment recommendations in a large urban teaching hospital. Acad Emerg Med 2005; 12:640-646.
23. Wiebe ER, Connor SE, McGregor M, et al. Offering HIV prophylaxis to people who have been sexually assaulted: 16 months' experience in a sexual assault service. Can Med Assoc J 2000; 162:641-645.
24. Roland ME, Neilands TB, Krone MR, et al. Seroconversion following nonoccupational postexposure prophylaxis against HIV. Clin Infect Dis 2005; 41:1507-1513.